Artificial Intelligence in Drug Metabolism and Excretion Prediction: Recent Advances, Challenges, and Future Perspectives

Drug metabolism and excretion play crucial roles in determining the efficacy and safety of drug candidates, and predicting these processes is an essential part of drug discovery and development. In recent years, artificial intelligence (AI) has emerged as a powerful tool for predicting drug metabolism and excretion, offering the potential to speed up drug development and improve clinical success rates. This review highlights recent advances in AI-based drug metabolism and excretion prediction, including deep learning and machine learning algorithms. We provide a list of public data sources and free prediction tools for the research community. We also discuss the challenges associated with the development of AI models for drug metabolism and excretion prediction and explore future perspectives in the field. We hope this will be a helpful resource for anyone who is researching in silico drug metabolism, excretion, and pharmacokinetic properties.

[1]  Connor W. Coley,et al.  Artificial intelligence foundation for therapeutic science , 2022, Nature Chemical Biology.

[2]  Vigneshwar Subramanian,et al.  Multi-task convolutional neural networks for predicting in vitro clearance endpoints from molecular images , 2022, Journal of Computer-Aided Molecular Design.

[3]  Hua Wu,et al.  HelixADMET: a robust and endpoint extensible ADMET system incorporating self-supervised knowledge transfer , 2022, Bioinform..

[4]  Jianping Lin,et al.  Interpretable-ADMET: a web service for ADMET prediction and optimization based on deep neural representation , 2022, Bioinform..

[5]  T. Aittokallio What are the current challenges for machine learning in drug discovery and repurposing? , 2022, Expert opinion on drug discovery.

[6]  X. Chu,et al.  Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development , 2022, Acta pharmaceutica Sinica. B.

[7]  Y. Terelius,et al.  Evaluation of ADMET Predictor in Early Discovery Drug Metabolism and Pharmacokinetics Project Work , 2022, Drug Metabolism and Disposition.

[8]  Bo Wang,et al.  HobPre: accurate prediction of human oral bioavailability for small molecules , 2022, Journal of Cheminformatics.

[9]  M. Loriot,et al.  Machine learning-driven identification of drugs inhibiting cytochrome P450 2C9 , 2022, PLoS Comput. Biol..

[10]  R. Greiner,et al.  HMDB 5.0: the Human Metabolome Database for 2022 , 2021, Nucleic Acids Res..

[11]  Y. Terelius,et al.  Evaluation of ADMET Predictor in Early Discovery Drug Metabolism and Pharmacokinetics Project Work , 2021, Drug Metabolism and Disposition.

[12]  Graham F. Smith Artificial Intelligence in Drug Safety and Metabolism. , 2021, Methods in molecular biology.

[13]  Yang Liu,et al.  Classification and prediction model of compound pharmacokinetic properties based on ensemble learning method , 2021, ISAIMS.

[14]  L. Kavraki,et al.  Machine learning models in the prediction of drug metabolism: challenges and future perspectives , 2021, Expert opinion on drug metabolism & toxicology.

[15]  Binh P. Nguyen,et al.  iCYP-MFE: Identifying Human Cytochrome P450 Inhibitors Using Multitask Learning and Molecular Fingerprint-Embedded Encoding , 2021, J. Chem. Inf. Model..

[16]  Vishwesh Venkatraman,et al.  FP-ADMET: a compendium of fingerprint-based ADMET prediction models , 2021, Journal of Cheminformatics.

[17]  Y. Uesawa,et al.  Prediction Model of Clearance by a Novel Quantitative Structure–Activity Relationship Approach, Combination DeepSnap-Deep Learning and Conventional Machine Learning , 2021, ACS omega.

[18]  J. Kirchmair,et al.  CYPlebrity: Machine learning models for the prediction of inhibitors of cytochrome P450 enzymes. , 2021, Bioorganic & medicinal chemistry.

[19]  R. Segurado,et al.  Genetic and Environmental Contributions to Variation in the Stable Urinary NMR Metabolome over Time: A Classic Twin Study , 2021, Journal of proteome research.

[20]  Weihua Li,et al.  In Silico Prediction of CYP2C8 Inhibition with Machine-Learning Methods. , 2021, Chemical research in toxicology.

[21]  David S. Wishart,et al.  CyProduct: A Software Tool for Accurately Predicting the Byproducts of Human Cytochrome P450 Metabolism , 2021, J. Chem. Inf. Model..

[22]  D. Thompson,et al.  Drug Metabolism in Drug Discovery and Preclinical Development , 2021, Drug Metabolism [Working Title].

[23]  Alya A Arabi,et al.  Artificial intelligence in drug design: algorithms, applications, challenges and ethics , 2021, Future Drug Discovery.

[24]  Aiping Lu,et al.  ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties , 2021, Nucleic Acids Res..

[25]  Tomoki Suzuki,et al.  Predicting drug metabolism and pharmacokinetics features of in-house compounds by a hybrid machine-learning model. , 2021, Drug metabolism and pharmacokinetics.

[26]  O. Silakari,et al.  Multiple machine learning, molecular docking, and ADMET screening approach for identification of selective inhibitors of CYP1B1 , 2021, Journal of biomolecular structure & dynamics.

[27]  Yurii S Moroz,et al.  ZINC20 - A Free Ultralarge-Scale Chemical Database for Ligand Discovery , 2020, J. Chem. Inf. Model..

[28]  J. Kirchmair,et al.  GLORYx: Prediction of the Metabolites Resulting from Phase 1 and Phase 2 Biotransformations of Xenobiotics , 2020, Chemical research in toxicology.

[29]  Bo-Han Su,et al.  Current development of integrated web servers for preclinical safety and pharmacokinetics assessments in drug development , 2020, Briefings Bioinform..

[30]  Gisbert Schneider,et al.  Drug discovery with explainable artificial intelligence , 2020, Nature Machine Intelligence.

[31]  Y. Kosugi,et al.  Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-up Approach Using In Vitro Assay. , 2020, Molecular pharmaceutics.

[32]  Hyun Kil Shin,et al.  PreMetabo: An in silico phase I and II drug metabolism prediction platform. , 2020, Drug metabolism and pharmacokinetics.

[33]  György M. Keserü,et al.  Large-scale evaluation of cytochrome P450 2C9 mediated drug interaction potential with machine learning-based consensus modeling , 2020, Journal of Computer-Aided Molecular Design.

[34]  R. Preissner,et al.  SuperCYPsPred—a web server for the prediction of cytochrome activity , 2020, Nucleic Acids Res..

[35]  Weihua Li,et al.  In silico prediction of human renal clearance of compounds using quantitative structure-pharmacokinetic relationship models. , 2020, Chemical research in toxicology.

[36]  Gary Siuzdak,et al.  METLIN: A Tandem Mass Spectral Library of Standards. , 2020, Methods in molecular biology.

[37]  Shiva Kumar,et al.  Multi-omics Data Integration, Interpretation, and Its Application , 2020, Bioinformatics and biology insights.

[38]  Jinyun Dong,et al.  Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors. , 2019, European journal of medicinal chemistry.

[39]  K. Mizuguchi,et al.  Development of an in silico prediction system of human renal excretion and clearance from chemical structure information incorporating fraction unbound in plasma as a descriptor , 2019, Scientific Reports.

[40]  Hu Mei,et al.  Molecular image-based convolutional neural network for the prediction of ADMET properties , 2019, Chemometrics and Intelligent Laboratory Systems.

[41]  Bernhard O. Palsson,et al.  BiGG Models 2020: multi-strain genome-scale models and expansion across the phylogenetic tree , 2019, Nucleic Acids Res..

[42]  Claire O'Donovan,et al.  MetaboLights: a resource evolving in response to the needs of its scientific community , 2019, Nucleic Acids Res..

[43]  Chao Shen,et al.  ADMET Evaluation in Drug Discovery. 19. Reliable Prediction of Human Cytochrome P450 Inhibition Using Artificial Intelligence Approaches , 2019, J. Chem. Inf. Model..

[44]  Z. Zuo,et al.  Current trends in drug metabolism and pharmacokinetics , 2019, Acta pharmaceutica Sinica. B.

[45]  Dong-Qing Wei,et al.  Prediction of CYP450 Enzyme-Substrate Selectivity Based on the Network-Based Label Space Division Method , 2019, J. Chem. Inf. Model..

[46]  Yan Yang,et al.  In Silico Prediction of Human Intravenous Pharmacokinetic Parameters with Improved Accuracy , 2019, J. Chem. Inf. Model..

[47]  Daniel Svozil,et al.  NERDD: a web portal providing access to in silico tools for drug discovery , 2019, Bioinform..

[48]  Flemming Steen Jørgensen,et al.  SMARTCyp 3.0: enhanced cytochrome P450 site-of-metabolism prediction server , 2019, Bioinform..

[49]  Daniel Svozil,et al.  FAME 3: Predicting the Sites of Metabolism in Synthetic Compounds and Natural Products for Phase 1 and Phase 2 Metabolic Enzymes , 2019, J. Chem. Inf. Model..

[50]  G. Schneider,et al.  Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery. , 2019, Chemical reviews.

[51]  Lei Jia,et al.  Chemi-Net: A Molecular Graph Convolutional Network for Accurate Drug Property Prediction , 2018, International journal of molecular sciences.

[52]  Daniel Svozil,et al.  GLORY: Generator of the Structures of Likely Cytochrome P450 Metabolites Based on Predicted Sites of Metabolism , 2019, Front. Chem..

[53]  Weiqi Wang,et al.  Computational Prediction of the Isoform Specificity of Cytochrome P450 Substrates by an Improved Bayesian Method , 2019 .

[54]  L. Wienkers,et al.  Handbook of Drug Metabolism, Third Edition , 2019 .

[55]  Ren Jun,et al.  In silico approaches and tools for the prediction of drug metabolism and fate: A review , 2019, Comput. Biol. Medicine.

[56]  Robert P Sheridan,et al.  Interpretation of QSAR Models by Coloring Atoms According to Changes in Predicted Activity: How Robust Is It? , 2019, J. Chem. Inf. Model..

[57]  Andreas Bender,et al.  Prediction of UGT-mediated Metabolism Using the Manually Curated MetaQSAR Database. , 2019, ACS medicinal chemistry letters.

[58]  T. Itoh,et al.  Design and synthesis of selective CYP1B1 inhibitor via dearomatization of α-naphthoflavone. , 2019, Bioorganic & medicinal chemistry.

[59]  K. Friedemann Schmidt,et al.  Predictive Multitask Deep Neural Network Models for ADME-Tox Properties: Learning from Large Data Sets , 2019, J. Chem. Inf. Model..

[60]  David S. Wishart,et al.  BioTransformer: a comprehensive computational tool for small molecule metabolism prediction and metabolite identification , 2019, Journal of Cheminformatics.

[61]  Hongbin Yang,et al.  Computational Prediction of Site of Metabolism for UGT-Catalyzed Reactions , 2018, J. Chem. Inf. Model..

[62]  Jinyun Dong,et al.  Design, Synthesis, and Biological Evaluation of Cytochrome P450 1B1 Targeted Molecular Imaging Probes for Colorectal Tumor Detection. , 2018, Journal of medicinal chemistry.

[63]  Andrew R. Leach,et al.  ChEMBL: towards direct deposition of bioassay data , 2018, Nucleic Acids Res..

[64]  Evan Bolton,et al.  PubChem 2019 update: improved access to chemical data , 2018, Nucleic Acids Res..

[65]  T. Maurer,et al.  Clearance in Drug Design. , 2018, Journal of medicinal chemistry.

[66]  Kenji Mizuguchi,et al.  Data Curation can Improve the Prediction Accuracy of Metabolic Intrinsic Clearance , 2018, Molecular informatics.

[67]  Jie Li,et al.  admetSAR 2.0: web‐service for prediction and optimization of chemical ADMET properties , 2018, Bioinform..

[68]  Franco Lombardo,et al.  Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds , 2018, Drug Metabolism and Disposition.

[69]  Volkan Atalay,et al.  Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases , 2018, Briefings Bioinform..

[70]  Jianfeng Pei,et al.  Prediction of Human Cytochrome P450 Inhibition Using a Multitask Deep Autoencoder Neural Network. , 2018, Molecular pharmaceutics.

[71]  David S. Wishart,et al.  CypReact: A Software Tool for in Silico Reactant Prediction for Human Cytochrome P450 Enzymes , 2018, J. Chem. Inf. Model..

[72]  Wei Tang,et al.  Drug metabolism in drug discovery and development , 2018, Acta pharmaceutica Sinica. B.

[73]  Sabina Podlewska,et al.  MetStabOn—Online Platform for Metabolic Stability Predictions , 2018, International journal of molecular sciences.

[74]  B. Testa,et al.  MetaQSAR: An Integrated Database Engine to Manage and Analyze Metabolic Data. , 2017, Journal of medicinal chemistry.

[75]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[76]  T. Maurer,et al.  Relevance of Half-Life in Drug Design. , 2017, Journal of medicinal chemistry.

[77]  S. Gad,et al.  Nonclinical Drug Administration: Formulations, Routes and Regimens for Solving Drug Delivery Problems in Animal Model Systems , 2017 .

[78]  Daniel Svozil,et al.  FAME 2: Simple and Effective Machine Learning Model of Cytochrome P450 Regioselectivity , 2017, J. Chem. Inf. Model..

[79]  Olivier Michielin,et al.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.

[80]  Andrew A Somogyi,et al.  Advances in drug metabolism and pharmacogenetics research in Australia , 2017, Pharmacological research.

[81]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[82]  Aleksandra Galetin,et al.  Novel minimal physiologically-based model for the prediction of passive tubular reabsorption and renal excretion clearance , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[83]  P. Neuvonen,et al.  Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions , 2016, Pharmacological Reviews.

[84]  Zhiheng Xu,et al.  OpenFDA: an innovative platform providing access to a wealth of FDA’s publicly available data , 2015, J. Am. Medical Informatics Assoc..

[85]  Bo-Han Su,et al.  Rule-Based Prediction Models of Cytochrome P450 Inhibition , 2015, J. Chem. Inf. Model..

[86]  Vladimir Poroikov,et al.  SOMP: web server for in silico prediction of sites of metabolism for drug-like compounds , 2015, Bioinform..

[87]  Bo-Han Su,et al.  CypRules: a rule-based P450 inhibition prediction server , 2015, Bioinform..

[88]  Dieter Lang,et al.  Predicting drug metabolism: experiment and/or computation? , 2015, Nature Reviews Drug Discovery.

[89]  Franco Lombardo,et al.  Clearance mechanism assignment and total clearance prediction in human based upon in silico models. , 2014, Journal of medicinal chemistry.

[90]  Xiaomin Luo,et al.  In silico site of metabolism prediction for human UGT-catalyzed reactions , 2014, Bioinform..

[91]  Sanjay Joshua Swamidass,et al.  XenoSite: Accurately Predicting CYP-Mediated Sites of Metabolism with Neural Networks , 2013, J. Chem. Inf. Model..

[92]  Robert C. Glen,et al.  FAst MEtabolizer (FAME): A Rapid and Accurate Predictor of Sites of Metabolism in Multiple Species by Endogenous Enzymes , 2013, J. Chem. Inf. Model..

[93]  Ulf Norinder,et al.  In silico categorization of in vivo intrinsic clearance using machine learning. , 2013, Molecular pharmaceutics.

[94]  Alessandro Pedretti,et al.  Reactions and enzymes in the metabolism of drugs and other xenobiotics. , 2012, Drug discovery today.

[95]  Igor V. Tetko,et al.  Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical information , 2011, J. Comput. Aided Mol. Des..

[96]  Rebecca Denton,et al.  A rapid computational filter for predicting the rate of human renal clearance. , 2010, Journal of molecular graphics & modelling.

[97]  Suzanne M. Paley,et al.  Beyond the genome (BTG) is a (PGDB) pathway genome database: HumanCyc , 2010, Genome Biology.

[98]  Antony J. Williams,et al.  ChemSpider:: An Online Chemical Information Resource , 2010 .

[99]  David E. Gloriam,et al.  SMARTCyp: A 2D Method for Prediction of Cytochrome P450-Mediated Drug Metabolism. , 2010, ACS medicinal chemistry letters.

[100]  R Scott Obach,et al.  Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. , 2010, Journal of medicinal chemistry.

[101]  Michael Schroeder,et al.  SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions , 2009, Nucleic Acids Res..

[102]  Jürgen Pleiss,et al.  The Cytochrome P450 Engineering Database: integration of biochemical properties , 2009, BMC Biochemistry.

[103]  Ruili Huang,et al.  Comprehensive Characterization of Cytochrome P450 Isozyme Selectivity across Chemical Libraries , 2009, Nature Biotechnology.

[104]  R. Obach,et al.  Physicochemical determinants of human renal clearance. , 2009, Journal of medicinal chemistry.

[105]  Yong Wang,et al.  Site of metabolism prediction for six biotransformations mediated by cytochromes P450 , 2009, Bioinform..

[106]  L. Wienkers,et al.  Handbook of Drug Metabolism , 2008 .

[107]  Lars Ridder,et al.  SyGMa: Combining Expert Knowledge and Empirical Scoring in the Prediction of Metabolites , 2008, ChemMedChem.

[108]  Jürgen Pleiss,et al.  The Cytochrome P450 Engineering Database: a navigation and prediction tool for the cytochrome P450 protein family , 2007, Bioinform..

[109]  Kiyoko F. Aoki-Kinoshita,et al.  From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..

[110]  R. Obach,et al.  Examination of 209 Drugs for Inhibition of Cytochrome P450 2C8 , 2005, Journal of clinical pharmacology.

[111]  J. Miners,et al.  Towards integrated ADME prediction: past, present and future directions for modelling metabolism by UDP-glucuronosyltransferases. , 2004, Journal of molecular graphics & modelling.

[112]  Tingjun Hou,et al.  ADME evaluation in drug discovery , 2002, Journal of molecular modeling.

[113]  Gregory Bock,et al.  'In silico' simulation of biological processes , 2002 .

[114]  Stefan Schiesser,et al.  Advances in the design of new types of inhaled medicines. , 2022, Progress in medicinal chemistry.

[115]  OUP accepted manuscript , 2021, Nucleic Acids Research.

[116]  Thomas R Larson,et al.  Drug Excretion , 2021, Reference Module in Biomedical Sciences.

[117]  Rodziah Atan,et al.  A Review on Integration of Scientific Experimental Data Through Metadata , 2019, Recent Trends and Advances in Wireless and IoT-enabled Networks.

[118]  A. Talevi,et al.  ADME Processes in Pharmaceutical Sciences , 2018, Springer International Publishing.

[119]  F. Guengerich Cytochrome p450 and chemical toxicology. , 2008, Chemical research in toxicology.

[120]  H. Matter,et al.  In-Silico ADME Modeling , 2006 .

[121]  Susumu Goto,et al.  The KEGG databases at GenomeNet , 2002, Nucleic Acids Res..